 NEW YORK, Aug. 18, 2020 GLOBE NEWSWIRE -- Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Mesoblast Limited NASDAQ: MESO resulting from allegations that Mesoblast may have issued materially misleading business information to the investing public.On August 11, 2020, the U.S. Food and Drug Administration FDA released briefing materials for the August 13, 2020 meeting of the FDAs Oncologic Drugs Advisory Committee, at which the FDA will review and discuss Mesoblasts marketing application for Ryoncil remestemcel-L for the treatment of steroid-refractory acute graft-versus-host disease in pediatric patients. The FDA briefing documents stated that it is unclear whether the study results supporting Mesoblasts application are relevant to the proposed indication for use.On this news, Mesoblasts stock price fell 6.09 per share, or 34.96, to close at 11.33 per share on August 11, 2020.Rosen Law Firm is preparing a securities lawsuit on behalf of Mesoblast shareholders. If you purchased securities of Mesoblast please visit the firms website at to join the securities action. You may also contact Phillip Kim of Rosen Law Firm toll free at 866-767-3653 or via email at or us for updates on LinkedIn: or on Twitter: or on Facebook: Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 3 each year since 2013. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firms attorneys are ranked and recognized by numerous independent and respected sources. Rosen Law Firm has secured hundreds of millions of dollars for investors.Attorney Advertising. Prior results do not guarantee a similar outcome.Contact Information: Laurence Rosen, Esq. Phillip Kim, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 40th Floor New York, NY 10016 Tel: 212 686-1060 Toll Free: 866 767-3653 Fax: 212 202-3827 